These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. Hobbs SD; Marshall T; Fegan C; Adam DJ; Bradbury AW J Vasc Surg; 2006 Jan; 43(1):40-6. PubMed ID: 16414385 [TBL] [Abstract][Full Text] [Related]
5. The fibrinolytic response to ancrod therapy: characterization of fibrinogen and fibrin degradation products. Prentice CR; Hampton KK; Grant PJ; Nelson SR; Nieuwenhuizen W; Gaffney PJ Br J Haematol; 1993 Feb; 83(2):276-81. PubMed ID: 8457476 [TBL] [Abstract][Full Text] [Related]
6. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension. Eisenberg PR; Lucore C; Kaufman L; Sobel BE; Jaffe AS; Rich S Circulation; 1990 Sep; 82(3):841-7. PubMed ID: 2394005 [TBL] [Abstract][Full Text] [Related]
7. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis]. Uchida Y Fukuoka Igaku Zasshi; 1991 Nov; 82(11):576-85. PubMed ID: 1774013 [TBL] [Abstract][Full Text] [Related]
8. Induction of marked thrombin activity by pharmacologic concentrations of plasminogen activators in nonanticoagulated whole blood. Eisenberg PR; Miletich JP Thromb Res; 1989 Sep; 55(5):635-43. PubMed ID: 2510363 [TBL] [Abstract][Full Text] [Related]
9. Fibrinolysis system in patients with bronchial asthma. Banach-Wawrzeńczyk E; Dziedziczko A; Rość D Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294 [TBL] [Abstract][Full Text] [Related]
10. [Contributory changes in variables of coagulation and fibrinolysis to the patency of coronary arteries in patients with acute myocardial infarction]. Miyauchi T Fukuoka Igaku Zasshi; 1991 Nov; 82(11):537-49. PubMed ID: 1774011 [TBL] [Abstract][Full Text] [Related]
11. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy]. Zalewska-Rydzkowska D; Rość D; Ponikowska I; Michalski A; Graczykowska-Koczorowska A; Rydzkowski M Pol Merkur Lekarski; 2001 Nov; 11(65):414-7. PubMed ID: 11852811 [TBL] [Abstract][Full Text] [Related]
12. Effect of physiological concentrations of vasopressin on components of the fibrinolytic system. Hariman H; Grant PJ; Hughes JR; Booth NA; Davies JA; Prentice CR Thromb Haemost; 1989 Apr; 61(2):298-300. PubMed ID: 2501900 [TBL] [Abstract][Full Text] [Related]
13. Sustained fibrinolysis after administration of t-PA despite its short half-life in the circulation. Eisenberg PR; Sherman LA; Tiefenbrunn AJ; Ludbrook PA; Sobel BE; Jaffe AS Thromb Haemost; 1987 Feb; 57(1):35-40. PubMed ID: 3109058 [TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic activity in peripheral atherosclerosis in the elderly. van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006 [TBL] [Abstract][Full Text] [Related]
15. Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest. Gando S; Kameue T; Nanzaki S; Nakanishi Y Thromb Haemost; 1997 Feb; 77(2):278-82. PubMed ID: 9157581 [TBL] [Abstract][Full Text] [Related]
16. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6. Kruithof EK; Mestries JC; Gascon MP; Ythier A Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401 [TBL] [Abstract][Full Text] [Related]
17. Prospective double-arm study of fibrinolysis in surgical patients. Kosir MA; Schmittinger L; Barno-Winarski L; Duddella P; Pone M; Perales A; Lange P; Brish LK; McGee K; Beleski K; Pawlak J; Mammen E; Sajahan NP; Kozol RA J Surg Res; 1998 Jan; 74(1):96-101. PubMed ID: 9536981 [TBL] [Abstract][Full Text] [Related]
18. Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia. Tallman MS; Lefèbvre P; Baine RM; Shoji M; Cohen I; Green D; Kwaan HC; Paietta E; Rickles FR J Thromb Haemost; 2004 Aug; 2(8):1341-50. PubMed ID: 15304040 [TBL] [Abstract][Full Text] [Related]
19. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells. Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873 [TBL] [Abstract][Full Text] [Related]
20. Peripheral artery disease in type 2 diabetes: the role of fibrinolysis. Lapolla A; Piarulli F; Sartore G; Rossetti C; Martano L; Carraro P; De Paoli M; Fedele D Thromb Haemost; 2003 Jan; 89(1):91-6. PubMed ID: 12540958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]